LATEST

• REGULATORY Wegovy’s MASH Label Expansion and More Up for Japan Panel Review on May 29
  May 18, 2026

• BUSINESS Kissei Urges Halt to New Tavneos Use after Fatal Liver Injury Reports
  May 18, 2026

• REGULATORY Japan Eyes June Submission of Immunization Act Bill to Cover Antibody Drugs
  May 18, 2026

• BUSINESS Eisai Hits Record Sales as Leqembi Revenue Nearly Doubles in FY2025
  May 18, 2026

• REGULATORY Calls Grow for Japan Version of EHDS at Regulatory Reform Panel
  May 18, 2026

• BUSINESS Kaken Files Vascular Malformation Drug in Japan, Eyes FY2027 Approval
  May 18, 2026

• ORGANIZATION Patient Group Pushes Emergency Steps to Address Concerta Supply Imbalances
  May 18, 2026

• BUSINESS Regenxbio Appeals FDA CRL for MPS II Gene Therapy RGX-121
  May 18, 2026

• BUSINESS Fuji Sees New Bio-AG Pricing Rules as Tailwind for Biosimilars
  May 18, 2026

• BUSINESS Astellas’ Izervay Accepted for Review in China for AMD
  May 18, 2026

• BUSINESS Espha to Reinvest AG Profits into New Biz after Reform; Xarelto AG Logs 19 Billion Yen
  May 15, 2026

• BUSINESS Meiji Opposes French Fund’s Push to Review Pharma Spin-Off
  May 15, 2026

• ORGANIZATION Labor Group Urges Priority Supply of Petrochemical Products for Drug Manufacturing
  May 15, 2026

• REGULATORY Japan OKs Coverage for Susmed Insomnia App, Shionogi ADHD Therapy App
  May 15, 2026

• BUSINESS FRONTEO Opens AI Drug Discovery Lab, Pivots to Out-Licensing Model
  May 15, 2026

• REGULATORY MHLW’s Mori Vows to Make Japan Pharma Market “More Attractive”
  May 15, 2026

• REGULATORY MHLW Official Says US MFN Policy Could Be Taken Up by Chuikyo
  May 15, 2026

• REGULATORY Oncolys’ Telomelysin Up for Japan Panel Review on May 21
  May 15, 2026

• BUSINESS Inqovi-Venetoclax Combo Wins FDA Approval in AML: Taiho
  May 15, 2026

• BUSINESS Chugai Files Gazyva for Idiopathic Nephrotic Syndrome in Japan
  May 15, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »